Real-time monitoring of brain energy metabolism in vivo using microelectrochemical sensors: the effects of anesthesia by Lowry, John P. & Fillenz, Marianne
Ž .Bioelectrochemistry 54 2001 39–47
www.elsevier.comrlocaterbioelechem
Real-time monitoring of brain energy metabolism in vivo using
microelectrochemical sensors: the effects of anesthesia
John P. Lowry a,), Marianne Fillenz b
a Neurochemistry Research Unit, Bioelectroanalysis Laboratory, Department of Chemistry, National UniÕersity of Ireland, Maynooth, Co. Kildare, Ireland
b UniÕersity Laboratory of Physiology, UniÕersity of Oxford, Parks Road, Oxford OX1 3PT, UK
Received 8 February 2001; received in revised form 30 April 2001; accepted 4 May 2001
Abstract
Ž . ŽRats were implanted in the striatum with a PtrIr electrode for measurement of regional cerebral blood flow rCBF H clearance2
.technique , a carbon paste electrode for monitoring tissue oxygen and a glucose biosensor for monitoring extracellular glucose. Changes
Ž . Žin all three parameters were recorded in response to the intraperitoneal i.p. administration of the anesthetics chloral hydrate 350
. Ž . Ž .mgrkg , sodium pentobarbitone 60 mgrkg and ketamine 200 mgrkg . An i.p. injection of normal saline, given as a control for the
injection of the anesthetics, produced a parallel increase in rCBF and tissue oxygen accompanied by a brief decrease in extracellular
glucose. Changes in tissue oxygen reflected the changes in rCBF; there was a decrease in both after sodium pentobarbitone, a decrease
followed by a rebound after ketamine and a transient increase after chloral hydrate. All three anesthetics produced a decrease in
extracellular glucose. The disparity between the changes in glucose and the changes in rCBF and oxygen suggests that during anesthesia,
the reduction in extracellular glucose is not due to a reduction in the direct delivery of glucose from the blood vascular system. These
results also indicate that levels of enzymatic substrates and mediators, which are intrinsic to the design and operation of amperometric
biosensors, are clearly altered in a complex manner by anesthesia and suggest that caution should be exercised in extrapolating data from
acute anesthetized experiments to normal physiology. q 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The application of electrochemistry in vivo involves the
use of amperometric electrodes and voltammetric tech-
niques for the detection of electroactive substances re-
w xleased from, and surrounding, nerve cells 1 . By implant-
ing microelectrochemical sensors in specific brain regions,
applying suitable potential profiles and recording the re-
sulting faradic currents, changes in the concentrations of a
variety of substances in the extracellular fluid can be
monitored with high time resolution. In recent years, the
range of species targeted has been extended to include
neurochemically important compounds that are either non-
electroactive or only poorly electroactive at analytically
useful potentials. This has been achieved through the use
of ‘first generation’ hydrogen peroxide-detecting micro-
electrochemical biosensors prepared by immobilizing a
sensitive and selective oxidoreductase enzyme on, or within
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close proximity of, an amperometric electrode. Extracellu-
w x w x w xlar levels of glucose 2–5 , lactate 6–8 , choline 9–12
w x Žand glutamate 13–16 have been measured in ‘acute’ i.e.
.non-recovery experiments where recording takes place
while the animal is still in the stereotaxic frame under the
influence of the anesthetic.
We have recently reported a number of investigations of
brain energy metabolism carried out in freely moving
wanimals using a specially designed glucose biosensor 17–
x20 . This sensor was prepared by immobilizing glucose
Ž .oxidase GOx onto platinum microelectrodes by trapping
the enzyme during electropolymerisation of poly-phenylen-
Ž .ediamine PPD on the electrode surface. The following
properties were characterized in detail both in vitro and in
w x Ž . Ž .vivo 21–24 : i high sensitivity to glucose; ii freedom
Žfrom fouling by endogenous matrix macromolecules lipids
. Ž .and proteins ; iii insignificant interference from reducing
agents, especially ascorbic acid normally present in high
Ž .concentration; and iv insensitivity to changes in oxygen
partial pressure.
In this study, we used these PtrPPDrGOx glucose
biosensors, in combination with other microelectrochemi-
1567-5394r01r$ - see front matter q 2001 Elsevier Science B.V. All rights reserved.
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cal sensors for rCBF and tissue oxygen, to monitor brain
metabolism in freely moving animals, before, during and
after anesthesia induced using normal induction doses of
three commonly used anesthetic agents: chloral hydrate,
sodium pentobarbitone and ketamine. The aim of this
research work was not only to examine the effect of
anesthesia on brain metabolism but also to investigate the
effects of anesthesia on baseline concentrations measured
using amperometric biosensors. A preliminary account of
some of these results has been communicated to the Physi-
Ž . w xological Society London 19 .
2. Materials and methods
2.1. Chemicals and solutions
The enzyme glucose oxidase from Aspergillus niger
Ž .EC 1.1.3.4, Grade I was obtained from Boehringer
Mannheim, East Sussex, UK. The o-phenylenediamine
Ž . Ž .free base , L-ascorbic acid AA; A.C.S. reagent and
Ž .ketamine hydrochloride were from Sigma, Dorset, UK.
Ž . Ž .D q -Glucose AnalaR grade and chloral hydrate were
obtained from BDH Laboratory Supplies, Poole, UK.
Ž .Sodium pentobarbitone 60 mgrkg was obtained from
Rhone Merieux, Essex, UK. The NaCl, NaH PO andˆ ´ 2 4
Ž .NaOH all BDH, AnalaR grade were used as supplied.
Carbon paste was prepared by thoroughly mixing 2.83 g of
Žcarbon powder UCP-1-M, Ultra Carbon, Bay City, MI,
. ŽUSA and 1.0 ml of silicone oil Aldrich Chemical, Dorset,
. w xUK, Catalogue No. 17,563-3 25 .
Ž .Stock glucose solutions 1 M for in vitro calibrations
were prepared, left for 24 h at room temperature to allow
equilibration of the anomers, and then stored at 4 8C. Stock
Ž .AA solutions 100 mM were prepared just before use
because of their gradual decomposition. All in vitro experi-
ments were carried out in a standard three-electrode glass
Ž .electrochemical cell capacity 25 ml in phosphate buffered
Ž . Ž . Žsaline PBS solution 20 ml , pH 7.4 150 mM NaCl, 40
.mM NaH PO and 40 mM NaOH . All solutions were2 4
prepared using deoxygenated doubly distilled deionised
water.
ŽIn in vivo experiments solutions of normal saline 0.5
. Ž .ml, 0.9% NaCl , chloral hydrate 350 mgrkg , pentobarbi-
Ž . Ž .tone 60 mgrkg and ketamine 200 mgrkg were admin-
istered i.p.
2.2. Preparation of electrochemical sensors
Glucose biosensors were based on the immobilization
Ž .of glucose oxidase GOx on Pt electrodes with the poly-
Ž . Ž .mer poly o-phenylenediamine PPD . PtrPPDrGOx
cylinder electrodes were prepared from 5 cm lengths of
Ž .Teflon-coated platinumriridium PtrIr 90%r10% wire
Ž Ž .125 mm bare diameter, 160 mm coated diameter 5-T ,
.Advent Research Materials, Suffolk, UK following a pre-
w xviously reported procedure 24 . Prior to implantation, all
PtrPPDrGOx electrodes were preconditioned in vitro by
continuous recording in 5 mM glucose over a 10-h period
w x24 . Electrodes were then calibrated in vitro for both
Ž . Ž .glucose 0–100 mM and AA 0–1 mM to ensure selec-
tivity and linearity of response of the sensor for glucose
w x22 .
Ž .Carbon paste disk electrodes CPEs for tissue O mea-2
surements were also made from 5 cm lengths of 5-T
w xTeflon-coated PtrIr wire 26 . In vitro calibrations for O2
were performed in N -purged, air-saturated and O -2 2
saturated solutions where the concentrations of solution O2
w x w xwere taken as 0, 200 27,28 and 1250 mM 27 , respec-
tively. The H detection electrodes for rCBF measure-2
Ž . Žments see Section 2.3 were made from 2-T 50 mm bare
.diameter, 75 mm coated diameter Teflon-coated PtrIr
w xwire as reported previously 26 .
2.3. Voltammetric techniques
Ž .Constant potential amperometry CPA at q700 mV
was used to oxidise the enzymatically produced H O at2 2
Žthe PtrPPDrGOx electrodes in vitro vs. an SCE refer-
. Žence electrode and in vivo vs. implanted Ag reference
.electrode, see Section 2.4 . Changes in O at CPEs were2
Ž .monitored using differential pulse amperometry DPA .
For O reduction, two equally sized cathodic pulses were2
applied, the first from a resting potential at y150 to y350
mV, which corresponds to the foot of the reduction wave
for O at lipid-modified CPEs, and the second from y3502
to y550 mV, which corresponds to the peak of the
Ž .reduction wave. The difference in the current D I sam-
pled during these respective pulse pairs was calculated and
changes in D I were used as a measure of changes in O ,2
w xwhich have been shown to be interference-free 29 . Be-
Ž .cause the CPE has a significant capacitance background ,
Ž .current mean value: y244.8"59.7 nA, ns23 changes
w xin the signal cannot be calculated as a percentage 26 .
Measurements of rCBF were performed using the H 2
clearance technique. CPA at q250 mV was used for H 2
oxidation. The methods of H administration and analysis2
used in these experiments have been described in detail in
w xa previous publication 26 . Briefly, the gas was adminis-
Žtered to the animals by simply holding PEEK tubing i.d.
.1.6 mm, o.d. 3.2 mm; Anachem, UK under the animal’s
snout for 10–20 s. This was tolerated extremely well by
the rats, which exhibited normal behaviour while it was
taking place. The tubing was connected through a flash-
back arrestor and a pressure regulator to a H cylinder2
Ž .zero grade, British Oxygen, UK , with the gas flow
controlled external to the rat’s bowl. The gas was adminis-
tered at approximately 5-min intervals and at a flow rate of
150 mlrmin. Blood flow measurements were performed
Ž .by starting the data acquisition LabVIEW program and
recording the baseline for 5 s. H was then administered2
until the current had increased by 30–80 nA. The decay
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curve was collected for a 3-min period. The first 30–60 s
of the curve was neglected and the remaining 120–240 s
were transferred to an analysis program. Here, a first-order
w Ž . xanalysis plot of ln i t y i vs. time t was per-baseline
formed. If a linear plot was obtained, the slope was
converted to blood flow. When the semi-log plot showed a
clear break in the slope, the decay curves before and after
the break point were analysed separately.
2.4. Surgical procedures
Male Sprague-Dawley rats weighing 200–300 g were
w xanesthetized, following published guidelines 30 , with a
Žmixture of Hypnorm Fentanyl citraterFluanisone, Janssen
. ŽPharmaceuticals, Oxford, UK , Hypnovel Midazolam,
.Roche Products, Herts, UK and sterile water, mixed 1:1:2
and injected i.p. at a volume of 3.3 mlrkg, as described
w xpreviously 17,31 . Once surgical anesthesia was estab-
lished, animals were placed in a stereotaxic frame and the
electrodes implanted following a previously described pro-
w xcedure 17 . Because the administration of H caused2
interference problems at the PtrPPDrGOx electrodes,
animals were implanted with either one of two combina-
Ž .tions of sensors: i a PtrPPDrGOx electrode, for moni-
Žtoring glucose, was implanted in the right striatum coordi-
nates with the skull leveled between bregma and lambda
were: ArP q1.0 from bregma, MrL q2.5 and DrV
w xy8.5 from dura 32 , and a carbon paste electrode, for
Žmonitoring tissue oxygen, in the left striatum coordinates:
ArPq1.0 from bregma, MrL y2.5 and DrV y5.0
. Ž .from dura ; ii a 2-T PtrIr electrode, for monitoring rCBF
by the H clearance method, was implanted in the right2
Žstriatum coordinates: ArP q1.0 from bregma, MrL
.q2.5 and DrV y8.5 from dura , and a carbon paste
electrode, for monitoring tissue oxygen, in the left striatum
Žcoordinates: ArP q1.0 from bregma, MrL y2.5 and
.DrV y5.0 from dura .
ŽA reference electrode 8-T Ag wire, 200 mm bare
.diameter; Advent Research Materials was placed in the
Ž .cortex, an auxiliary electrode 8-T Ag wire placed be-
Ž .tween the skull and dura, and an earth wire 8-T Ag wire
attached to one of the support screws. The reference
potential provided by the Ag wire in brain tissue is very
w xsimilar to that of the SCE 33 . The electrodes and probe
were fixed to the skull with dental screws and dental
Ž .acrylate Associated Dental Products, Swindon, UK .
Surgery typically lasted 40 min and anesthesia was re-
Ž .versed by an i.p. injection of naloxone 0.1 mgrkg, Sigma .
Post-operative analgesia was provided in the form of a
Ž .single injection 0.1 mgrkg, s.c. of Vetergesic
ŽBuprenorphine hydrochloride, Reckitt and Colman Phar-
.maceuticals, Hull, UK given immediately following the
surgery. Animals were allowed to recover after surgery
and were assessed for good health according to published
w xguidelines 34 immediately after recovery from anesthesia
and at the beginning of each day. This work was carried
Žout under license in accordance with the Animals Scien-
.tific Procedures Act, 1986.
2.5. Experimental conditions
ŽRats were housed in large plastic bowls diameter ca.
.50 cm , in a windowless room under a 12-h light, 12-h
dark cycle, lights coming on at 8:00 a.m., with free access
to water. Food was available ad libitum. All experiments
were carried out with the animal in its home bowl. Im-
planted electrodes were connected to the potentiostat at
least 60 min prior to the start of each experiment, through
a six-pin Teflon socket, and a flexible screened six-core
cable, which was mounted through a swivel above the rat’s
Ž .head Semat Technical, Herts, UK . This arrangement
allowed free movement of the animal. Once the back-
ground currents for the various sensors had stabilized
Žtypically 30–45 min for the PtrPPDrGOx glucose elec-
trodes, 5–10 min for the O CPEs, and 30 min for the2
.rCBF PtrIr electrodes , experiments were begun. All sig-
Ž .nals were recorded at 2-s intervals see Section 2.6 .
2.6. Instrumentation and software
ŽA low-noise potentiostat Biostat II, Electrochemical
.and Medical Systems, Newbury, UK was used in all
experiments. For CPA experiments, either a Macintosh IIx
computer or a Mitac 486 PC was used with data acquisi-
Žtion performed using National Instruments NI, National
.Instruments, Austin, TX, USA multifunction data acquisi-
Ž .tion boards: NB-MIO-16X Macintosh and AT-MIO-16
Ž .PC . Further noise reduction was achieved by averaging
Ž . Ž .75 Mac and 100 PC determinations to give 1 data point
every 2 s. For DPA experiments, all data acquisition was
performed on a Mitac 486 PC with data sampling per-
formed at a rate of 250 determinationsrpulse and averaged
w xto give 1 data pointrpulse 29 . A complete pulse sequence
was performed every 2 s. All experiments were performed
Žusing in-house developed software: PC LabWindows, NI
. Ž .version 2.1 ; Macintosh LabVIEW, NI version 2.2.1 . All
analyses were performed using both in-house developed
software and the commercial packages Igor Pro 2.0
Ž . ŽWaveMetrics, OR, USA and Prism GraphPad Software,
.CA, USA .
The significance of differences observed was estimated
Žusing the Student’s t-test for paired observations StatView,
.Abacus Concepts, CA, USA . Two-tailed levels of signifi-
cance were used and P-0.05 was considered to be
significant. All data are presented as mean"S.E.M.
3. Results
3.1. Effect of saline injection
Since the anesthetics were administered by i.p. injec-
tion, we first examined the effect of i.p. injection of
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Ž .normal saline NaCl 0.9% . A typical example of changes
in rCBF, tissue oxygen and extracellular glucose is shown
in Fig. 1.
There was an immediate increase in rCBF and oxygen
following injection. rCBF increased by 30"11 mlr100
Ž .grmin from a baseline of 79"6 mlr100 grmin ns6 .
Fig. 1. A typical example of the effect of intraperitoneal injection of
Ž .normal saline 0.5 ml, NaCl 0.9% on A regional cerebral blood flow
Ž .rCBF , B tissue oxygen, and C extracellular glucose, monitored with a
Ž .PtrIr H clearance electrode, a carbon paste electrode, and a glucose2
biosensor respectively, in the striatum of freely moving rats. Inset:
Close-up of the PtrPPDrGOx glucose signal recorded during the saline
injection. Arrows indicate the points of injection.
This represents an increase of 35"11%. The oxygen
signal increased maximally by 13.5"3.7 nA at 2.5"0.4
Ž .min and had returned to baseline by 4.1"3.7 min ns4 .
This increase in current corresponds to an increase in
concentration of 50"15 mM based on calculations from
in vitro calibration curves. Because measurements of rCBF
are carried out at 5-min intervals, the duration of the
changes in rCBF for injection of normal saline cannot be
determined accurately. By contrast, the carbon paste elec-
trode gives a continuous measurement of oxygen current.
The latter can be used as an index of the increase in rCBF
w x26 and therefore provides an accurate measure of the
duration of the rCBF increase.
The glucose electrode also gives a continuous signal
Ž .for extracellular glucose and provides an accurate mea-
w xsure of the duration of any changes 18 . On injection of
normal saline, it exhibited a very brief decrease of 1.2"0.4
Ž .nA from a baseline of 7.2"1.6 nA ns5 . This repre-
sents a percentage decrease of 20"7% and corresponds to
a change in concentration of 34"7 mM. The duration of
the decrease was 0.7"0.2 min.
For all three parameters, there was no significant differ-
ence in the baseline signals before and after the brief
injection effects with the baseline values remaining stable
Ž .for up to 40-min post injection: Ps0.6317 rCBF , Ps
Ž . Ž .0.3882 oxygen , Ps0.2254 glucose .
3.2. Effect of anesthetics
The intraperitoneal injection of each of the anesthetic
agents produced the same initial response as the i.p. saline
injection; a brief increase in rCBF and oxygen and an even
shorter decrease in glucose. This was followed by slower
more long-lasting changes, which accompanied the behav-
ioral changes associated with anesthesia. The duration of
Žanesthesia as measured by reflex responses palpebral,
.corneal and withdrawal reflexes and spontaneous move-
ments of the rats were similar for the three anesthetics at
Ž . Ž .the doses see Section 2.1 used: 92"6 min ns10 for
Ž .chloral hydrate, 90"6 min ns7 for pentobarbitone and
Ž .78"4 min ns11 for ketamine.
3.3. Chloral hydrate
Ž .Chloral hydrate see Fig. 2 produced a sharp increase
in rCBF from 90"12 mlr100 grmin to a maximum of
Ž .266"65 mlr100 grmin P-0.05, ns5 at 18"2 min
after the administration of the anesthetic. This represents a
percentage increase of 201"60%. It then declined to
control levels, which it reached when the rats began to
show recovery from the anesthesia. The changes in oxygen
current closely followed the changes in rCBF. There was a
maximum increase in oxygen current of 18.7"3.1 nA
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Fig. 2. A typical example of the effect of intraperitoneal injection of
Ž . Ž .chloral hydrate 350 mgrkg on A regional cerebral blood flow rCBF ,
B tissue oxygen, and C extracellular glucose, monitored in rat striatum.
Arrows indicate the points of injection of, and recovery from, the
anesthetic.
Ž .P-0.03, ns10 at 11.6"1.9 min. This corresponds to
an increase in concentration of 69"9 mM.
The change in glucose by contrast was in a different
direction. Chloral hydrate caused a maximum decrease in
glucose current of 2.3"0.5 nA from a baseline of 8.6"1.1
Ž .nA P-0.02, ns5 at 64"7 min. This represents a
decrease of 26"5%, and corresponds to a change in
concentration of 80"18 mM from a baseline value of
311"50 mM.
3.4. Sodium pentobarbitone
Ž .Sodium pentobarbitone see Fig. 3 produced a steep
decrease in rCBF from a baseline of 107"14 mlr100
Žgrmin to a minimum of 64"16 mlr100 grmin P-
.0.04, ns3 at 42"4 min after the administration of the
anesthetic. This represents a percentage decrease of 34"
7%. This was followed by a slow recovery that failed to
reach control levels 2 h after initial administration of the
anesthetic, when rats showed full behavioral recovery. The
Fig. 3. A typical example of the effect of intraperitoneal injection of
Ž .sodium pentobarbitone 60 mgrkg on A regional cerebral blood flow
Ž .rCBF , B tissue oxygen, and C extracellular glucose, monitored in rat
striatum. Arrows indicate the points of injection of, and recovery from,
the anesthetic.
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changes in oxygen current closely followed the changes in
rCBF. There was a maximum decrease in oxygen current
Ž .of 21.4"5.6 nA P-0.02, ns6 at 27"4 min. This
represents a decrease of 67"13 mM.
The change in glucose was in the same direction.
Pentobarbitone caused a maximum decrease in glucose
current of 1.7"0.4 nA from a baseline of 7.1"0.5 nA
Ž .P-0.04, ns4 at 54"9 min. This represents a de-
Fig. 4. A typical example of the effect of intraperitoneal injection of
Ž . Ž .ketamine 200 mgrkg on A regional cerebral blood flow rCBF , B
tissue oxygen, and C extracellular glucose, monitored in rat striatum.
Arrows indicate the points of injection of, and recovery from, the
anesthetic.
crease of 25"8%, and corresponds to a change in concen-
tration of 64"19 mM from a baseline concentration of
258"17 mM.
3.5. Ketamine
Ž .Ketamine see Fig. 4 produced a biphasic change in
rCBF; there was an initial decrease from 93"8 mlr100
Žgrmin to a minimum of 75"5 mlr100 grmin P-0.01,
.ns5 at 20"2 min, followed by a rapid rebound to a
Ž .maximum of 156"18 mlr100 grmin P-0.01, ns5
at 93"9 min after drug administration. This represents a
decrease of 19"2% and an increase of 65"6%, respec-
tively. The rebound accompanied intense motor activity as
the rats were recovering from the anesthesia. The changes
in oxygen current closely followed the changes in rCBF.
There was a maximum decrease in oxygen current of
Ž .11.7"1.9 nA P-0.02, ns7 at 18"7 min. This
represents a decrease of 43"11 mM. The rebound was
Ž .15.4"3.8 nA P-0.02, ns7 at 88"10 min. This
represents an increase of 41"6 mM.
The change in glucose was in the same direction.
Ketamine caused a maximum decrease in glucose current
Žof 1.6"0.3 nA from a baseline of 8.6"3.2 nA P-0.01,
.ns6 at 54"6 min. This represents a percentage de-
crease of 24"6%, and corresponds to a change in concen-
tration of 95"39 mM from a baseline value of 316"61
mM.
4. Discussion
Chloral hydrate, sodium pentobarbitone and ketamine
are three commonly used non-volatile anesthetic agents for
animal surgery. They cause general CNS depression with
different mechanisms of action. Chloral hydrate is rapidly
metabolized into trichloroethanol and trichloroacetic acid
w x35 . Trichloroethanol is suspected to be the active sub-
w xstance for inducing anesthesia 36 because, similar to
barbiturates, it has the ability to prolong chloride influx
w xinduced by exogenous GABA 37 . Sodium pentobarbitone
is a lipophilic compound, which acts on the GABAA
receptor inducing anesthesia by enhancing GABA-media-
w xted transmission 38 . Ketamine causes an anesthetic state
that is mediated by non-competitive inhibition of NMDA
w xreceptors 39 .
A detailed literature survey of previous investigations of
the effects of anesthesia on brain energy metabolism re-
veals a limited number of studies monitoring different
metabolic parameters. It has been shown that both pento-
barbitone and chloral hydrate cause a lowering of systemic
w xblood pressure 40 and a decrease in glucose utilization
w x w x41,42 . Pentobarbitone reduces cerebral blood flow 43,44 ,
w xwhereas for ketamine, both a decrease 45 and an increase
w x46 have been reported. Based on the accumulation of
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radiolabelled glucose, it has also been estimated that there
is little increase in extracellular glucose in pentobarbitone
w x w xanesthesia 43 . Fellows et al. 47 reported the effect of
Ž .chloral hydrate 500 mgrkg i.p. on dialysate glucose
levels in rat striatum and observed a rapid sustained in-
Ž .crease. However, microdialysis non-quantitative provides
only an indirect measure of extracellular glucose, which
depends on the in vivo recovery of the microdialysis
probe. This cannot be derived from the in vitro probe
w xrecovery 48 . To the best of our knowledge, there are no
previous real-time measurements of the effects of anesthe-
sia on extracellular brain glucose concentrations.
The hydrogen clearance technique, used in the present
study, provides a direct measure of rCBF in absolute units.
The oxygen and glucose currents are continuous measure-
ments and represent the balance between supply and uti-
lization. Since the changes in oxygen are parallel to the
changes in rCBF, we propose that they represent changes
in blood flow. The immediate effect of the i.p. injection,
whether saline or anesthetic, is similar to the effect of
w xneuronal activation described in our previous paper 17 ,
Ž .where during the 5-min period of stimulation tail pinch ,
there is an increase in rCBF and oxygen current and a
decrease in extracellular glucose. The latter decrease was
followed by a delayed increase during which both rCBF
and oxygen had returned to basal levels; with the brief
stimulus of the i.p. injection, the delayed increase in
extracellular glucose was absent.
There was an immediate increase in rCBF and oxygen
and a decrease in glucose following saline injection. The
increase in rCBF occurred in only the first of the 5-min
measurements after the injection and there was a return to
a stable baseline by the next one. The effect of the
injection on oxygen and glucose was also brief being less
than 4 min for oxygen and less than 1 min for glucose.
Thereafter, the baseline values remained stable for the
Žduration of recording ca. 40-min post injection effect, see
.Fig. 1 . Similar initial and brief injection effects have also
been observed during the injection of the anesthetic agents,
with a comparable return to baseline levels occurring
before the effect of the anesthetic takes place and the
w xanimal becomes anesthetized 19 . The stress of the i.p.
w xinjection stimulates neuronal activation 49 , increasing
rCBF and oxygen, and decreasing glucose through an
increase in neuronal glucose utilization.
Although with all three anesthetics extracellular glucose
was reduced, the relationship between glucose and rCBF
differed between the anesthetics. While the reduction in
both glucose and rCBF after pentobarbitone suggests a
reduction in glucose supply, the decrease in glucose ac-
companied by a transient increase in rCBF after chloral
hydrate suggests an increase in glucose utilization. This is
supported by reports that chloral hydrate causes an in-
crease in the basal firing rate of dopaminergic neurons in
w xthe substantia nigra 50,51 , and a recent real-time in vivo
voltammetric study where increased release of dopamine
in the striatum was reported after chloral hydrate adminis-
w xtration 52 . However, the effect of chloral hydrate on
striatal dopamine release is controversial; microdialysis
experiments have been reported where no change in basal
w x w xlevels 53 and where a decrease in basal levels 54 were
observed.
The difference, not only in direction but also in time
course, between the changes in rCBF and glucose, is
clearly shown in Figs. 2, 3 and 4: the changes in rCBF and
oxygen are always parallel and have the same time course.
The change in glucose by contrast is in a different direc-
tion after chloral hydrate and although in the same direc-
tion after pentobarbitone and ketamine is very much slower.
The classical model of brain metabolism suggests that
glucose is supplied to the extracellular compartment di-
rectly from the cerebrovascular compartment; changing
energy requirements in this model are met by changes in
local cerebral blood flow and there is close coupling
w xbetween glucose delivery and blood flow 55 . The ob-
served disparity between the changes in glucose and the
changes in rCBF and oxygen suggests that extracellular
glucose in the brain is not derived directly from the blood
vascular system but must come from some other intermedi-
ate compartment. Recent evidence suggests that this is
likely to represent astrocytes, which now appear to play a
w xcentral role in the delivery of metabolic substrates 56 .
Several studies have previously been carried out com-
paring experiments performed in conscious and anes-
thetized rats indicating significant differences resulting
from the effects of the different anesthetics investigated.
These have focused on dopamine, DOPAC, 5-HT and
HVA and have primarily involved the use of microdialysis
w xtechniques 36,53,54,57 , although some voltammetric
studies of dopamine have been made with carbon paste
w x w x58 and carbon fiber electrodes 52 . Recently, several
groups have used in vivo voltammetry with ‘first genera-
tion’ amperometric enzyme-based biosensors to monitor
brain extracellular levels of several non-electroactive ana-
w xlytes under anesthesia in acute experiments 2–5,7–16 .
The findings of the present experiments suggest that cau-
tion must be exercised in extrapolating results from such
acute experiments to the conscious state. This is especially
true for estimations of basal concentrations, as extracellu-
lar levels of enzymatic substrates are clearly altered in a
complex manner by anesthesia.
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